| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/07/2001 | WO2001055307A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055306A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055304A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055303A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055302A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055301A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055300A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055208A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055207A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055204A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055203A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055202A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055201A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055200A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055168A8 Nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001055163A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001055162A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001054733A8 Nucleic acids, proteins and antibodies |
| 09/07/2001 | WO2001054473A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001054472A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001032898A3 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 09/07/2001 | WO2001025432A3 Histamine receptor |
| 09/07/2001 | WO2001023575A3 Wuschel (wus) gene homologs |
| 09/07/2001 | WO2001018202A3 Flint analog compounds and formulations thereof |
| 09/07/2001 | WO2001016169A3 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 09/07/2001 | WO2001016163A3 Peptide mixture and vaccine against a chronic viral infection |
| 09/07/2001 | WO2001015741A3 Genetic suppressor elements against human immunodeficiency virus |
| 09/07/2001 | WO2001014413A3 Polypeptides capable of interacting with the smad peptide and comprising the sequence pp (t/n)k |
| 09/07/2001 | WO2001014395A3 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 09/07/2001 | WO2001012812A3 Baff receptor (bcma), an immunoregulatory agent |
| 09/07/2001 | WO2001011937A3 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 09/07/2001 | WO2001010469A3 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 09/07/2001 | WO2001009355A3 PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF |
| 09/07/2001 | WO2001009163A3 Improvement of peptide transport by conjugation with bile acids |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000078119A3 Cardiomyocytes with enhanced proliferative potential |
| 09/07/2001 | WO2000075358A3 Mammalian toll homologues and uses thereof |
| 09/07/2001 | WO2000075326A8 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use |
| 09/07/2001 | WO2000046384A9 Nucleic acid uptake and release vehicle |
| 09/07/2001 | WO2000046383A3 Method of modulating metabolite biosynthesis in recombinant cells |
| 09/07/2001 | EP1144637A3 Wuschel (wus) gene homologs |
| 09/07/2001 | CA2744921A1 Hybrid expression of neisserial proteins |
| 09/07/2001 | CA2689666A1 Heterologous expression of neisserial proteins |
| 09/07/2001 | CA2402054A1 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | CA2401989A1 A method of treatment |
| 09/07/2001 | CA2401963A1 Maurocalcine, analogues thereof and their therapeutical uses |
| 09/07/2001 | CA2401958A1 Multiple gene expression for engineering novel pathways and hyperexpression of foreign proteins in plants |
| 09/07/2001 | CA2401858A1 Embryo sac-specific genes |
| 09/07/2001 | CA2401775A1 Diagnostics and therapeutics for glaucoma |
| 09/07/2001 | CA2401755A1 Vaccine for the treatment of artherosclerosis |
| 09/07/2001 | CA2401741A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof |
| 09/07/2001 | CA2401716A1 Methods for promoting production of myelin by schwann cells |
| 09/07/2001 | CA2401690A1 Novel human proteins and polynucleotides encoding the same |
| 09/07/2001 | CA2401683A1 Design and discovery of protein based tnf-.alpha. variants for the treatment of tnf-.alpha. related disorders |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401645A1 Novel human transporter proteins and polynucleotides encoding the same |
| 09/07/2001 | CA2401633A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase .beta./.zeta. |
| 09/07/2001 | CA2401628A1 Sulfated ccr5 peptides for hiv-1 infection |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401606A1 Caspase-inhibitory-factor (cif) and uses thereof |
| 09/07/2001 | CA2401550A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | CA2401544A1 Renilla reniformis green fluorescent protein and mutants thereof |
| 09/07/2001 | CA2401505A1 Novel nucleic acids and polypeptides |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401343A1 A method of treatment and prophylaxis |
| 09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2400679A1 Human schizophrenia gene |
| 09/07/2001 | CA2400595A1 Human schizophrenia gene |
| 09/07/2001 | CA2400058A1 Protein scaffolds for antibody mimics and other binding proteins |
| 09/07/2001 | CA2399886A1 Leafy cotyledon1 genes and their uses |
| 09/07/2001 | CA2399847A1 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
| 09/06/2001 | US20010020300 Transgenic pathogen-resistant organism |
| 09/06/2001 | US20010020086 Peptide chimera comprising polysaccharide-binding domain and second domain comprising factor XIIIa substrate and/or peptide, useful for enhancing healing of tissues of vasculature, skin, nervous systems, and the liver |
| 09/06/2001 | US20010020010 Polypeptide |
| 09/06/2001 | US20010020005 Administering a gastrin inhibitor |
| 09/06/2001 | US20010020004 Wound healing agents, antiulcer agents, vision defects |
| 09/06/2001 | US20010020003 Polypeptides |
| 09/06/2001 | US20010019839 Method for production of a C1 esterase inhibitor (C1-INH)-containing composition |
| 09/06/2001 | US20010019834 Genetic engineering |
| 09/06/2001 | US20010019833 TNF receptor-specific antibodies |
| 09/06/2001 | US20010019828 Generating an immune response to lymphoma |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | US20010019714 Hiv-specific cytotoxic t-cell responses |
| 09/06/2001 | US20010019713 Novel interleukin compositions and methods of use |
| 09/06/2001 | DE10061931A1 A new nucleic acid encoding M73791 HUMNOVGENE also known as HUMQM and human RPL10 is involved in tumor suppression and useful to diagnose and treat cancer |
| 09/06/2001 | DE10006887A1 Modulators of regulatory protein RS1, useful for treating diabetes or tumors and for increasing drug transport, control concentration of transport proteins in plasma membranes |
| 09/05/2001 | EP1130396A1 Measuring method and measuring reagent of C-reactive protein |
| 09/05/2001 | EP1130394A1 In vitro models of CNS function and dysfunction |
| 09/05/2001 | EP1130123A2 Diagnostic method |
| 09/05/2001 | EP1130099A1 Activated vitronectin as a marker of angiogenesis detected with phage antibodies |
| 09/05/2001 | EP1130098A2 Mammalian osteoregulins |
| 09/05/2001 | EP1130097A1 Control of membrane traffic |
| 09/05/2001 | EP1130096A1 Proliferation arrest trancription factor (PATF) and its use |
| 09/05/2001 | EP1130095A1 Control of membrane traffic |
| 09/05/2001 | EP1130094A2 Primers for synthesizing full length cDNA clones and their use |
| 09/05/2001 | EP1130089A1 Composition comprising membrane virus subviral target and fusion particles and vaccine comprising said composition |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130031A1 Method for inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity |
| 09/05/2001 | EP1130030A1 Human erythroid differentiation related factor |